BioSpace News Archive

Business

Day One Appoints Saira Ramasastry to Board of Directors

Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers, today announced the appointment of Ms. Saira Ramasastry to the Company’s board of directors.

April 12, 2021
·
5 min read
Drug Development

Genprex Collaborators Report Positive Preclinical Data for REQORSA™ Immunogene Therapy in Non-Small Cell Lung Cancer at the 2021 AACR Annual Meeting

REQORSA Enhances Efficacy of Chemo-Immune Combination Therapy in KRAS-LKB1 Mutant NSCLC in Humanized Mice REQORSA Overcomes Resistance to Targeted Therapy Osimertinib

April 12, 2021
·
8 min read
Biotech Bay

New Study, with Pear Therapeutics, to Identify Best Practices for Implementation in Primary Care of Digital Treatment for Substance Use Disorders

Pear Therapeutics, Inc. announced an effort to provide health system leaders with evidence-based data on best practices for implementation of prescription digital therapeutics for substance use disorder and opioid use disorder in primary care.

April 12, 2021
·
7 min read
BioForest

Kineta Presents New Preclinical Data on its Lead VISTA Antagonist Antibody at the AACR Annual Meeting 2021

Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced today the presentation of new preclinical data on its VISTA antagonist antibody at the American Association for Cancer Research (AACR) Annual Meeting 2021.

April 12, 2021
·
3 min read
Business

Horizon Therapeutics plc Named One of the Fortune 100 Best Companies to Work For®

Horizon Therapeutics plc Named One of the Fortune 100 Best Companies to Work For ® - Company also named to the 2021 Best Places to Work in Chicago list by Crain’s Chicago Business -

April 12, 2021
·
4 min read
Drug Development

Akston Biosciences Launches Phase I/II Clinical Trial of Second-Generation COVID-19 Vaccine

First subjects dosed with AKS-452, COVID-19 vaccine candidate in the Netherlands trial Vaccine is shelf-stable for 4 months at 25 degrees Celsius (77° Fahrenheit) 176 volunteers will participate in the clinical trial

April 12, 2021
·
5 min read
Pharm Country

Applied UV Receives Patent for Pathogen Destroying Devices in China

Adds to Company’s Portfolio of Patents for Disinfection Technology Addressing Global Challenge of Controlling the Spread of Emerging Pathogens

April 12, 2021
·
4 min read
BioMidwest

Stereotaxis CEO Invited as Keynote Speaker at Robotic Surgery & Enabling Technologies Summit 2021

Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that David Fischel, Chairman and CEO, will serve as the keynote speaker at the Robotic Surgery & Enabling Technologies Virtual Summit 2021.

April 12, 2021
·
3 min read
Drug Development

SOTIO Demonstrates Strong Potential of SOT102 (ADC Targeting Claudin 18.2) for Treatment of Solid Tumors in Preclinical Studies

SOTIO, a clinical stage immuno-oncology company owned by PPF Group,announced new preclinical data of its antibody-drug conjugate (ADC), SOT102 (formerly SO-N102), for the treatment of solid tumors in a virtual poster presentation at the 2021 American Association of Cancer Research (AACR) Annual Meeting.

April 12, 2021
·
2 min read
BioMidwest

Prime Therapeutics’ study shows total cost of care for CAR-T plus post-treatment events can exceed $1 million

Blue Cross and Blue Shield plans can better forecast and manage the total cost of chimeric antigen receptor T-cell (CAR-T) therapies for members with relapsed or refractory B-cell lymphoma by putting Prime Therapeutics LLC (Prime) insights into action.

April 12, 2021
·
4 min read